MedPath

Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus

Not Applicable
Conditions
Osteochondral Lesion of Talus
Interventions
Other: Extracorporeal Shock Wave Therapy
Registration Number
NCT03750253
Lead Sponsor
Southwest Hospital, China
Brief Summary

Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study aims to investigate the clinical efficacy of shock wave adjuvant therapy in the treatment of postoperative pain caused by cartilage injury of talus after arthroscopy and to provide basis for further popularization and application.

Detailed Description

Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study was conducted to investigate the clinical efficacy of shock wave therapy in the treatment of postoperative pain caused by cartilage injury of talus after arthroscopy.

Patients with osteochondral lesions of the talus treated by arthroscopic microfracture surgery and still complained ankle pain three months after surgery were enrolled. Radial extracorporeal shock wave therapy was used to give energy to the injured region of the talus and the adjacent area.Treatment was done once a week for 5 consecutive weeks. After shock wave therapy,the patients were followed by Visual Analogue Scale (VAS), the American Orthopaedic Foot and Ankle Society ankle-hindfoot scale(AOFAS-AHFS) , and followed finally by Magnetic Resonance Imaging(MRI) of the ankle.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  1. For arthroscopy:

    • Ankle pain, aggravated after exercise or weight-bearing activity, accompanied by lameness, joint stiffness and dysfunction for at least 3 months
    • No talar collapse
    • Talar cartilage injury cases before stage Ⅳ of Hepple classification
  2. For shock wave therapy:

    • Patients with micro-fractures treated with arthroscopic treatment of talar cartilage injury and were treated with routine rehabilitation training after arthroscopy
    • Patients who till complained obvious ankle pain 3 months after surgery
Exclusion Criteria
  • Severe cardiovascular and cerebrovascular diseases
  • Hemorrhagic diseases, coagulation disorders
  • Bone immaturity
  • Thrombosis
  • Use of anti-immune agents
  • Various types of tumor patients
  • Pregnant women
  • History of mental illness
  • Patients who could not be followed
  • Patients with other lower extremity injuries after surgery and were unwilling to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Extracorporeal Shock Wave TherapyExtracorporeal Shock Wave TherapyExtracorporeal Shock Wave Therapy to relieve pain after arthroscopy for osteochondral lesions of talus
Primary Outcome Measures
NameTimeMethod
Change of VAS scores before and after shock wave therapy6 weeks, 12 weeks and last follow-up at an average of 2 years after shock wave therapy

The Visual Analogue Scale scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-10 points, and decreases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value \< 0.05 is considered as statistically significant.

Secondary Outcome Measures
NameTimeMethod
Change of AOFAS scores before and after shock wave therapy6 weeks, 12 weeks and last follow-up last follow-up at an average of 2 years after shock wave therapy

The American Orthopaedic Foot \& Ankle Society scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-100 points, and increases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value \< 0.05 is considered as statistically significant.

Trial Locations

Locations (1)

Southwest Hospital

🇨🇳

Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath